期刊文献+

血清CA19-9和血浆FIB水平在良、恶性梗阻性黄疸鉴别诊断中的价值 被引量:6

Differential diagnosis value of serum CA19-9 level combined with plasma FIB level between benign and malignant obstructive jaundice
下载PDF
导出
摘要 目的:评价血清糖类抗原19-9(CA19-9)和血浆纤维蛋白原(FIB)水平在良、恶性梗阻性黄疸鉴别诊断中的价值。方法:收集60例良性和75例恶性梗阻性黄疸患者,采用全自动免疫分析仪经电化学发光法检测血清CA19-9,采用全自动血栓/止血分析仪经光学法检测血浆FIB,绘制ROC曲线,确定诊断界值,计算特异度及灵敏度。结果:恶性梗阻性黄疸患者血清CA19-9及血浆FIB水平均高于良性梗阻性黄疸患者(Z=7.420,6.862,P<0.05)。 ROC曲线分析结果显示:AUC(CA19-9)为0.872,95%可信区间(0.813~0.931);AUC(FIB)为0.844,95%可信区间(0.777~0.912)。取灵敏度+特异性的最高值所对应的截断点作为诊断界点,CA19-9的界点为35.085 U/mL,FIB为2.45 g/L,2者在选定界点的灵敏度(95%可信区间)分别为88.0%(82.5%~93.5%)和84.0%(77.8%~90.2%),联合检测灵敏度增加至98.7%(98.2%~99.2%)。结论:血清CA19-9与血浆FIB联合检测可提高良、恶性梗阻性黄疸鉴别诊断的灵敏度。 Aim:To explore the value of serum carbohydrate antigen 19-9(CA19-9) combined with plasma fibrinogen ( FIB) for the differential diagnosis of benign and malignant obstructive jaundice .Methods:A total of 60 benign obstruc-tive jaundice patients and 75 malignant obstructive jaundice patients were subjected to detect the serum CA 19-9 and plasma FIB.The serum CA19-9 was detected via the electrochemical luminescence method .The plasma FIB was detected via the optics method.The diagnostic performance of CA 19-9 and FIB in the benign and malignant obstructive jaundice was evalua-ted with ROC curve .Results:The levels of CA19-9 and FIB of the malignant obstructive jaundice patients were signifi-cantly higher than those of benign patients (Z=7.420,6.862,P〈0.05).The AUC(CA19-9) and AUC(FIB) of ROC curve were 0.872 and 0.844,and 95%CI was (0.813-0.931) and (0.777-0.912).When the cut-off point was deter-mined as 35.085 U/mL for CA19-9 and 2.45 g/L for FIB on the basis of highest value of sensitivity and specificity , thesensitivity(95%CI) of CA19-9, FIB, and combined detection were 88.0%(82.5% -93.5%),84.0%(77.8% -90.2%), and 98.7%(98.2% -99.2%).Conclusion: The combined detection of CA19-9 and FIB can improve thesensitivity of differential diagnosis of benign and malignant obstructive jaundice .
出处 《郑州大学学报(医学版)》 CAS 北大核心 2013年第5期661-663,共3页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省科技攻关计划项目102102310115
关键词 糖类抗原19-9 纤维蛋白原 梗阻性黄疸 鉴别诊断 carbohydrate antigen 19-9 fibrinogen obstructive jaundice differential diagnosis
  • 相关文献

参考文献12

  • 1Bhat K, Wang F, Ma Q, et al. Advances in biomarker re- search for pancreatic cancer [ J ]. Curr Pharm Des,2012, 18(17) :2439.
  • 2Charbel H, A1-Kawas FH. Cholangiocarcinoma: epidemi- ology, risk factors, pathogenesis, and diagnosis[ J]. Curr Gastroenterol Rep,2011,13 (2) : 182.
  • 3Battistelli S, Stefanoni M, Lorenzi B, et al. Coagulation factor levels in non-metastatic colorectal cancer patients [J]. Int J Biol Markers, 2008,23(1) :36.
  • 4Lee SE, Lee JH, Ryu KW, et al. Preoperative plasma fi- brinogen level is a useful predictor of adjacent organ in- volvement in patients with advanced gastric cancer [ J ]. J Gastric Cancer, 2012,12 ( 2 ) : 81.
  • 5Witte KK, Ford SJ, Preston T, et al. Fibrinogen synthesis is increased in cachectic patients with chronic heart failure [J]. IntJ Cardiol,2008,129(3):363.
  • 6Davalos D, Akassoglou K. Fibrinogen as a key regulator of inflammation in disease [ J ]. Semin Immunopathol, 2012, 34( 1 ) :43.
  • 7Schmidt C. Early detection tools for pancreatic cancer[ J]. J Natl Cancer Inst,2012,104 ( 15 ) : 1117.
  • 8胰腺癌诊疗规范(2011年版)[J].临床肿瘤学杂志,2011,16(11):1026-1032. 被引量:20
  • 9何浪,杨耀琴.肿瘤标记物在原发性胆囊癌诊断中的意义[J].同济大学学报(医学版),2004,25(5):438-440. 被引量:9
  • 10孙雅君.纤维蛋白原和癌胚抗原联合检测在胃肠道恶性肿瘤中的临床意义[J].肿瘤基础与临床,2012,25(2):108-110. 被引量:2

二级参考文献26

  • 1Asano T,Shoda J,Ueda T,et al.Expression of cyclooxygenase-2 and prostaglandin E-receptors in carcinoma of the gallbladder:crucial role of arachidonate metabolism in tumor growth and progression [J].Clin Cancer Res,2002,8(4):1157-1167.
  • 2Rozengurt E,Walsh JH.Gastrin,CCK,Signaling and Cancer [J].Annu Rev Physiol,2001,63(3):49-76.
  • 3Noguchi Yoshikazu,Saito Aya ,Yohei Miyagi ,et al .Suppression of facilitative glucose transporter 1 mRNA can suppress tumor growth [J].Cancer Lett,2000,154(2) :175-182.
  • 4Kim YW,Park YK,Yoon TY,et al .Expression of the GLUT1 glucose transporter in gallbladder carcinomas [J].Hepatogastroenterology,2002 ,49(46) :907-911.
  • 5Sanjeev M,Arun C,Naresh CM,et al .Carcinoma of the gallbladder [J].Oncol 2003,4(3):167-176.
  • 6Gately S.The contribution of cyclooxygenase-2 to tumor angiogenesis [J].Cancer Metastasis Rev,2000,19(1-2):19-27.
  • 7St Laurent M,Esterl RM Jr,Halff GA,et al.Gallbladder carcinoma producing alpha-fetoprotain [J].J Clin Gastroenterol,1999,28(2):155-158.
  • 8Wongkham S,Sheehan JK,Boonla C,et al.Serum MUC5AC mucin as a potential marker for cholangiocarcinoma [J].Cancer Lett.2003 ,195(1):93-99.
  • 9Verhulst ML,Hopman WP,et al.Effects of Helicobacter pylori infection on endocrine and exocrine mucosal functions in the upper gastrointestinal tract [J].Scand J Gastroenterol,2000,232(Suppl):21-31.
  • 10Caplin M,Khan K,et al.Expression and processing of gastrin in hepatocellular carcinoma,fibrolamellar carcinoma and cholangiocarcinima [J].J Hepatol,1999,30(3):519-526.

共引文献63

同被引文献74

  • 1黄春雷,廖朝兴.超声引导下PTCD治疗治疗恶性梗阻性黄疸的临床疗效及安全性分析[J].实用心脑肺血管病杂志,2020,28(S01):83-85. 被引量:4
  • 2Mehrdad Moghimi,Seyed Ali Marashi,Mohammad Taghi Salehian,Mehrdad Sheikhvatan.Obstructive jaundice in Iran:factors affecting early outcome[J].Hepatobiliary & Pancreatic Diseases International,2008,7(5):515-519. 被引量:9
  • 3Daniele Marrelli,Stefano Caruso,Corrado Pedrazzani,Alessandro Neri,Eduardo Fernandes,Mario Marini,Enrico Pinto,Franco Roviello.CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions[J].The American Journal of Surgery.2009(3)
  • 4Tsuyuguchi T,Takada T,Miyazaki M,et al.Stenting and Interventional Radiology for Obstructive Jaundice in Patients with Unresectable Biliary Tract Carcinomas[J].Journal of hepato-biliary-pancreatic surgery,2008,15(1):69-73.
  • 5Ferlitsch A,Oesterreicher C,Dumonceau J-M,et al.Diamond Stents for Palliation of Malignant Bile Duct Obstruction:A Prospective Multicenter Evaluation[J].Endoscopy,2001,33(8):645-50.
  • 6夏念信,邱宝安,祝建勇,等.同期原发肝外胆管和胆囊肿瘤一例[J].中华临床医师杂志:电子版,2013(8):3686-3688.
  • 7Kasuga A, Ishii H, Ozaka M, et al. Clinical outcome oi: biliary drainage for obstructive jaundice caused by colo rectal and gastric cancers[J]. Jpn J Clin Oncol,2012,42(12):1161-1167.
  • 8Yalav O, Yati murO, l.)lkti A, et al. A rare cause of obstructive jaundice: Fasciola hepatica mimicking cholangiocarcinoma[J]. Turk J Gastroenterol, 2012, 23(5) : 604-607.
  • 9Tonack S, Jenkinson C, Cox T, et al. iTRAQ reveals candidate pancreatic cancer serum biomarkers., influ- ence of obstructive jaundice on their performancei'J]. Br J Cancer,2013,108(9) :1846-1853.
  • 10Helling TS. Caution in interpretation of the tumor marker CA 19.9 in patients with obstruct -tire jaun- dice:illustrative case reports [J]. J Miss State Med Assoc, 2013,54(4) : 96-99.

引证文献6

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部